Oruka Therapeutics, Inc. ORKA Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period?
- Oruka Therapeutics, Inc. (ORKA) reported share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period of 78K in Q1 2026.
- What does share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period mean?
- Tracks the total number of share-based payment awards, such as stock options, that were forfeited or expired during the period. High levels of forfeitures may indicate high employee turnover or performance targets that were not met. This metric is useful for adjusting the expected dilution impact of stock-based compensation plans.